Beste Komplexe Diagnostik der Schilddrüse Diagnostiker - TOP-71 Ärzte

Assoz. Prof. Nuri Alper Şahbaz ist ein erfahrener Arzt mit medizinischer Ausbildung an der Medizinischen Fakultät der Cerrahpaşa-Universität Istanbul sowie wissenschaftlicher und klinischer Erfahrung am Baylor College of Medicine und der University of Texas Medical School. Er ist spezialisiert auf endokrine Chirurgie (Schilddrüsen-, Nebenschilddrüsen-, Nebennieren- und neuroendokrine Tumore) und hat in diesem Bereich über 2000 erfolgreiche Operationen durchgeführt. Er ist außerdem spezialisiert auf laparoskopische und minimal-invasive Operationen sowie auf diagnostische und therapeutische Endoskopie des Magen-Darm-Systems.

Was born in 1981 in Erzincan. After finishing Beşiktaş Atatürk Anadolu High School in 1999 entered Istanbul University Çapa, Faculty of Medicine. 

In 2005 I got his Master Degree and started as a practitioner at Yüksekova State Hospital. He got his Doctorate at Okmeydanı Training and Research Hospital in General Surgery department. As a General Surgery Specialist, he worked at Zonguldak Atatürk State Hospital for 5 years and at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for 3 years. 

Worked as an Assistant Professor at Istanbul Medipol University, Department of General Surgery. Currently working at Medipol University Pendik Hospital. 

Education:

2021 ULUDAĞ ÜNİVERSİTESİ, KULAK BURUN BOĞAZ HASTALIKLARI

2014 EGE ÜNİVERSİTESİ, TIP FAKÜLTESİ

Experience:

2023 - 2023 SAĞLIK BİLİMLERİ ÜNİVERSİTESİ SULTAN ABDÜLHAMİD HAN EĞİTİM VE ARAŞTIRMA HASTANESİ

2021 - 2022 ŞEHİT PROF.DR. İLHAN VARANK SANCAKTEPE EĞİTİM VE ARAŞTIRMA HASTANESİ

Professor für Medizin, Leiter der Abteilung für Endokrinologie und Stoffwechsel, Medizinische Fakultät, Medizinische Universität Wien. Mitarbeit in mehreren Organisationen, wie der Sektion Endokrinologie der Europäischen Union der Fachärzte und der Österreichischen Gesellschaft für Endokrinologie. Über 300 Veröffentlichungen in Fachzeitschriften mit Peer-Review zu den Bereichen klinische, Grundlagen- und translationale Forschung.

Dr. ist Teamleiterin der Chirurgischen Endokrinologie an der Medizinischen Universität Wien. Er ist Facharzt für Allgemein- und Viszeralchirurgie und promovierter Mediziner (2005). Er hat mehrere Konferenzen organisiert und ist Mitglied mehrerer medizinischer Gesellschaften. Derzeit ist er Leiter der Arbeitsgruppe Chirurgische Endokrinologie an der Medizinischen Universität Wien. Er erhielt 2017 den Venia Docendi Award und 2010 den Sandoz Award for Thyroid Research.

• Bildung
• Sackler Medizinische Fakultät, Universität Tel Aviv
• Spezialisierung
• Pädiatrie, Pädiatrische Endokrinologie
• Anerkannte Erfahrung
• Facharzt für Pädiatrie, Facharzt für pädiatrische Endokrinologie.
• Zusätzliche Ausbildung
• 2002-2005 Praktikum in der Pädiatrischen Endokrinologie, Cincinnati Children's Hospital, Ohio, USA
• 2005-2006 Pädiatrisches Neuroendokrinologie-Praktikum, Cincinnati Children's Hospital, Ohio, USA.
• Klinische Erfahrung
• 1998-2001 Spezialisierung auf Pädiatrie, Dana Children's Hospital, Sourasky Medical Center, Tel Aviv
• 2002 Leitender Kinderarzt, Dana Children's Hospital, Sourasky Medical Center, Tel Aviv
• 2002-2005 - Spezialisierung auf pädiatrische Endokrinologie, Cincinnati Children's Hospital, Ohio, USA.
• 2005-2006 Pädiatrisches Neuroendokrinologie-Praktikum, Cincinnati Children's Hospital, Ohio, USA.
• 2006-2008 Leitender pädiatrischer Endokrinologe, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer
• Seit 2007 pädiatrischer Endokrinologe, Maccabi Health Services
• Seit 2008 Senior Pediatric Endocrinologist, Dana-Duak Children's Hospital, Sourasky Medical Center, Tel Aviv
• Seit 2010 Direktor der Klinik für endokrine und juvenile Diabetes, Dana-Duak Children's Hospital, Sourasky Medical Center, Tel Aviv
• Seit 2011 Direktor der Pädiatrischen Neuroendokrinologie, Dana-Duak Children's Hospital, Sourasky Medical Center, Tel Aviv
• Akademische Erfahrung
• 2008-2013 Klinischer Ausbilder, Abteilung für Pädiatrie, Medizinische Fakultät. Sackler-Universität Tel Aviv
• 2013-2019 Dozent, Abteilung für Pädiatrie, Medizinische Fakultät Sackler, Universität Tel Aviv.
• Seit 2019 Senior Clinical Lecturer, Department of Pädiatrie, Medizinische Fakultät. Sackler-Universität Tel Aviv
• Konferenzteilnahme
• Etwa 30 Vorträge auf wissenschaftlichen Konferenzen
• Fachpublikationen
• Etwa 30 Fachpublikationen
• Gemeinschaftsmitgliedsschaft
• Israelische Ärztekammer
• Israelische Vereinigung für pädiatrische Endokrinologie
• Israelischer Verband der Endokrinologen
• Interessensgebiete und Aktivitäten
• Endokrinologie und Diabetes bei Kindern, Neuroendokrinologie

Dr. Ilana Itzhakov ist Endokrinologin am Ichilov Medical Center (Tel-Aviv Sourasky Medical Center).

Professor, Facharzt für pädiatrische Endokrinologie

Education and Experience

• 1992 - 1998, Gaziantep University, Faculty of Medicine
• 2002 – 2015, Cumhuriyet University, Faculty of Medicine, Department of Internal Medicine
• 2015 – 2024, Bağcılar Medipol Mega University Hospital
• 2024 – Present, Medipol Acıbadem Hospital

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

2014 : The world's first robotic oral thyroidectomy developed by Kim Hoon-yub

2011 ~ : Fellow of the International Society of Neuro Monitoring Research

2008 ~ : Permanent member of Korean Society of Endoscopic & Laparoscopic Surgeons

2008 ~ : Permanent member of Korean Society of Surgical Oncology

2008 ~ : Permanent member of the Asia Oceania Thyroid Association

2014 ~ : Research Professor, the Korean Society of Endoscopic & Laparoscopic Surgeons

2014 ~ : Member of planning Committee at the Korean Association of Thyroid and Endocrine Surgeons, member of the Medical Rights Advisory Committee

2012 ~ : Member of the International Surgery Research Forum

2015 ~ : Member of the American Thyroid Association

2015 ~ 2016: Research Professor, Division of Head and Neck Surgery, Johns Hopkins University School of Medicine, USA

Medical Interests 

Obesity 

Insulin resistance 

Diabetes 

Hypoglycemia (low sugar) 

Growth retardation and short stature 

Anorexia 

growth hormone deficiency 

Puberty problems (early puberty, delayed puberty, excessive hair growth, menstrual irregularity, polycystic ovary syndrome) 

Turner syndrome 

Thyroid diseases (Goiter, hypothyroidism, hyperthyroidism, Hashimoto’s disease, thyroid nodule) 

Sexual development disorders (small penis, undescended testis, gender ambiguity, hypospadias) 

Adrenal gland diseases (Congenital adrenal hyperplasia, Addison’s disease, Cushing’s syndrome) 

Bone and calcium metabolism diseases (rickets, vitamin D deficiency, osteoporosis) 

Education 

Bachelor’s - Master’s: Ankara University Faculty of Medicine (1998-2004) 

Ph.D. - Specialization in Medicine: Child Health and Diseases, Dr. Sami Ulus Gynecology and Childhood Health and Diseases Training and Research Hospital (2005-2010) 

Ph.D. - Minor specialization: Pediatric Endocrinology, Dokuz Eylul University Faculty of Medicine (2010-2013) 

Experience 

Child Health and Diseases Specialist Diyarbakır Children’s Hospital 2010 

Pediatric Endocrine Minor Assistant Dokuz Eylül University Medical Faculty Hospital 2010-2014 

Pediatric Endocrinology Specialist İzmir Tepecik Training and Research Hospital 2014-2015 

Assistant Professor Izmir Katip Celebi University Faculty of Medicine 2015-2016 

Associate Professor Izmir Katip Celebi University Faculty of Medicine 2016-2021 

Pediatric Endocrinology Associate Professor Ulus Liv Hospital 2021- Present 

Pediatric Endocrinology Associate Professor Vadistanbul Liv Hospital 2021- Present

Memberships 

Aegean Child Endocrine and Diabetes Association, Member, 2010 

Pediatric Endocrinology and Diabetes Association, Member, 2010 

Growing Child Association, Member, 2014 

European Society of Pediatric Endocrinology (ESPE), Member, 2016

Experience 

• 2016 - 2017

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

• 2016 - 2017

Liv Hospital

• 2016 - 2017

Liv Hospital Ulus

• 2015 - 2016

Acıbadem Bodrum Hospital

• 2014 - 2015

Tatvan State Hospital

• 2013 - 2015

Tatvan State Hospital

• 2012 - 2013

CLEVELAND CLINIC

• 2007 - 2014

Dokuz Eylul University Faculty of Medicine

Education 

• 2013

DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY

• 2013

Dokuz Eylül University, General Surgery

• 2007

AKDENİZ UNIVERSITY, FACULTY OF MEDICINE

• 2007

International Peer-Reviewed Journal Articles:

Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.

• Authors: AĞALAR CİHAN, SÖKMEN SELMAN, ARSLAN ÖZŞAHİN NACİYE ÇİĞDEM, ALTAY CANAN, BAŞARA AKIN IŞIL, CANDA ARAS EMRE, OBUZ FUNDA
• Journal: Techniques in Coloproctology
• Year: 2020
• Volume: 24(4)
• Pages: 301-308
• DOI: 10.1007/s10151-020-02159-z
• Publication Number: 6776368

Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.

• Authors: Terzi Cem, Bingül Mustafa, ARSLAN NACİYE ÇİĞDEM, ÖZTÜRK ERSİN, CANDA ARAS EMRE, IŞIK ÖZGEN, YILMAZLAR AHMET TUNCAY, OBUZ FUNDA, Görken Birkay, KURT MERAL, ÜNLÜ ŞADİYE MEHTAT, UĞRAŞ NESRİN, Kanat Özkan, ÖZTOP İLHAN
• Journal: Colorectal Disease
• Year: 2020
• Volume: 22(3)
• Pages: 279-288
• DOI: 10.1111/codi.14867
• Publication Number: 6012919

Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.

• Authors: ÖZDENKAYA YAŞAR, OLMUŞÇELİK OKTAY, BASIM PELİN, SAKA BURCU, ARSLAN NACİYE ÇİĞDEM
• Journal: Acta Cirurgica Brasileira
• Year: 2019
• Volume: 34(8)
• Publication Number: 5242669

Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.

• Authors: CANDA ARAS EMRE, ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, YAVUZŞEN TUĞBA, Ozkardesler Sevda, Unlu Mehtat, OBUZ FUNDA, FÜZÜN MEHMET
• Journal: World Journal of Surgical Oncology
• Year: 2018
• Volume: 16(1)
• Pages: 70-74
• DOI: 10.1186/s12957-018-1369-7
• Publication Number: 4863133

Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.

• Authors: Atasoy Gulsen, ARSLAN NACİYE ÇİĞDEM, Elibol Funda, SAĞOL ÖZGÜL, OBUZ FUNDA, SÖKMEN SELMAN
• Journal: Surgery Today
• Year: 2018
• Volume: 48(12)
• Pages: 1040-1051
• DOI: 10.1007/s00595-018-1690-3
• Publication Number: 4863005

Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

• Authors: Terzi Cem, Sokmen Selman, ARSLAN NACİYE ÇİĞDEM, Ozkardesler Sevda, DURAL CEMIL, OBUZ FUNDA, CANDA ARAS EMRE, GÖKTÜRK ÜMIT KELEŞTEN
• Journal: International Journal of Surgery
• Year: 2018
• Volume: 51
• Pages: 156-160
• DOI: 10.1016/j.ijsu.2018.01.010
• Publication Number: 4855751

Contributions to Conferences:

Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.

• Authors: CANDA ARAS EMRE, Sokmen Selman, Terzi Cem, ARSLAN NACİYE ÇİĞDEM, OBUZ FUNDA
• Conference: European Society of Surgical Oncology (ESSO) Congress
• Year: 2018
• Location: Budapest, Hungary

Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.

• Authors: ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, CANDA ARAS EMRE, OBUZ FUNDA
• Conference: European Association for Endoscopic Surgery (EAES) Congress
• Year: 2017
• Location: Frankfurt, Germany